We provide evidence that TAF are derived from mesenchymal stem cells (MSC) that acquire a TAF phenotype following exposure to or systemic recruitment into adenocarcinoma xenograft models including breast, pancreatic, and ovarian.
The TZDs troglitazone and ciglitazone demonstrate antiproliferative activities in several cancer models including breast cancer [ 23].
CCM regulates p21 expression through a p53-dependent pathway in several cellular models, including breast cancer cells [ 44, 46- 49].
Emerging evidence continually recognizes tumor-specific metastamiRs in many tumor models, including breast, lung, prostate, colorectal, gastric, and head and neck cancer.
This combination resulted in significant survival improvements in multiple murine tumour models, including breast and ovarian cancers, and was well tolerated.
MiR-21 has been shown to stimulate cell invasion and metastasis in several tumor models, including breast cancer [ 12], colon cancer [ 17], and glioma [ 18].
Human tumor xenograft models included breast (LM2-4LUC+) (etos et al, 2008), melanoma (WM113/6-4L WM113/6-4Loz et al, 2008), and kidney (SN12-PM6LUC+) cell lines in SCID mice, whiletalmouse syngenic model utilized the kidney cell line (RENCALUC+) (Tracz et al, 2008) in Band/c.
Other cancers that have well-known risk-prediction models include breast (Gail et al, 1989; Tyrer et al, 2004; Tice et al, 2005), colorectal (Imperiale et al, 2000; Selvachandran et al, 2002), melanoma (Cho et al, 2005; Fears et al, 2006), ovarian (Hartge et al, 1994), and bladder cancers (Wu et al, 2007).
We observed an AUC of 0.738 for the model with Gail factors, BMI and the SNP panel, which is higher than the AUC observed in the general population for the Gail model alone (0.596) or the Gail model including breast density (0.634) [ 46].
The Barlow model includes breast density, hormone replacement therapy, body mass index, result of previous mammography exams, race and ethnicity as risk factors.
The difference in AR between the Gail and Chen models was due to the fact that the Chen model includes breast density and therefore the baseline risk is considerably lower.
